These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 221657)

  • 1. Effect of human and murine neutrophils on encephalomyocarditis, vesicular stomatitis, and reo type 3 virus infections in tissue culture.
    Faden HS; Keller N; Ogra PL
    J Reticuloendothel Soc; 1978 Dec; 24(6):629-36. PubMed ID: 221657
    [No Abstract]   [Full Text] [Related]  

  • 2. Rat interferons. VI. Heterologous interferon in the treatment of viral infections.
    Lobodzińska M; Albin M
    Arch Immunol Ther Exp (Warsz); 1979; 27(1-2):247-52. PubMed ID: 220932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study on risk factors for transplacental viral infections; effect of bacterial factors and double viral infections on virus replication in placenta and amniotic membranes.
    Jatczak B; Gejdel E; Pajak J; Podwińska J; Błach-Olszewska Z
    Placenta; 2001 Apr; 22(4):360-71. PubMed ID: 11286573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Formation of interferon in the brain of baby mice after injection with some rhabdoviruses].
    Hofmann H; Kunz C
    Zentralbl Bakteriol Orig; 1969; 211(1):5-9. PubMed ID: 4393905
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of ammonium 5-tungsto-2-antimoniate on encephalomyocarditis and vesicular stomatitis virus infections in mice.
    Werner GH; Jasmin C; Chermann JC
    J Gen Virol; 1976 Apr; 31(1):59-64. PubMed ID: 177729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimal molecular and cellular requirements for elicitation of secondary anti-vesicular stomatitis virus cytotoxic T lymphocytes.
    Hale AH; Ruebush MJ
    J Immunol; 1980 Oct; 125(4):1569-77. PubMed ID: 6251135
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of cyclosporine on encephalomyocarditis virus infection in mice.
    Zhang XQ; Ho M
    Proc Chin Acad Med Sci Peking Union Med Coll; 1988; 3(2):72-8. PubMed ID: 2848238
    [No Abstract]   [Full Text] [Related]  

  • 8. Neutralizing antibodies against IFN beta in patients with multiple sclerosis: a comparative study of two cytopathic effect tests (CPE) for their detection.
    Oliver B; Orpez T; Mayorga C; Pinto-Medel MJ; Leyva L; López-Gómez C; Marín C; Luque G; Ortega-Pinazo J; Fernández O
    J Immunol Methods; 2009 Dec; 351(1-2):41-5. PubMed ID: 19786034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon induction in New Zealand black mice by murine leukemia virus.
    Siegel BV; Brown M; Morton JI
    J Immunol; 1973 Aug; 111(2):644-6. PubMed ID: 4123984
    [No Abstract]   [Full Text] [Related]  

  • 10. Susceptibility to virus infection is determined by a Stat-mediated response to the autocrine effect of virus-induced type I interferon.
    Improta T; Pine R
    Cytokine; 1997 Jun; 9(6):383-93. PubMed ID: 9199872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleic acid as interferon inducer. Its antiviral and antitumor activity.
    Feldmane G; Loza V; Duks A; Yesyacova I; Vinkele R; Buike A; Meldrajs J; Erele I
    Arch Immunol Ther Exp (Warsz); 1977; 25(5):693-700. PubMed ID: 202217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility to murine viral diabetes: host versus intrinsic pancreatic factors.
    Dafoe DC; Naji A; Barker CF
    Transplant Proc; 1981 Mar; 13(1 Pt 2):829-31. PubMed ID: 6267754
    [No Abstract]   [Full Text] [Related]  

  • 13. Elicitation and specificity of anti-vesicular stomatitis virus-specific cytotoxic T lymphocytes.
    Ruebush MJ; Hale AH; Lefrancois L; Harris DT; Burgess DE
    J Immunol; 1981 May; 126(5):2053-9. PubMed ID: 6260862
    [No Abstract]   [Full Text] [Related]  

  • 14. Augmentation of delayed-type hypersensitivity to serum proteins by vesicular stomatitis virus infection in mice: virus-suppressor cell interactions.
    Katsura Y; Takaoki Y; Minato N
    J Immunol; 1982 Jul; 129(1):362-5. PubMed ID: 6177756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limitation of VSV infection by the host's response to VSV-associated cellular antigens.
    Hecht TT; Paul WE
    J Immunol; 1982 Oct; 129(4):1736-41. PubMed ID: 6180021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathogenesis of virus-induced diabetes (a review of the literature)].
    Zhurba TB; Shirobokov VP
    Vrach Delo; 1985 Oct; (10):1-5. PubMed ID: 3004041
    [No Abstract]   [Full Text] [Related]  

  • 17. Virus plaque assay and enumeration of effector cells in mixed lymphocyte cultures.
    Bloom BR; Kano S; Howe ML
    Transplant Proc; 1973 Dec; 5(4):1705-9. PubMed ID: 4359723
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiviral effects of recombinant human tumor necrosis factor.
    Ito M; O'Malley JA
    Lymphokine Res; 1987; 6(4):309-18. PubMed ID: 2448553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility and serological response of cattle, pigs, horses and goats to Indiana2 and Indiana3 strains of vesicular stomatitis virus.
    Yedloutschnig RJ; Dardiri AH
    Proc Annu Meet U S Anim Health Assoc; 1977; (81):276-83. PubMed ID: 220637
    [No Abstract]   [Full Text] [Related]  

  • 20. Pathogenesis of vesicular stomatitis virus infection in the infant hamster and mouse.
    Bruno-Lobo M; Peralta PH; Bruno-Lobo GG; de Paola D
    An Microbiol (Rio J); 1968; 15():53-68. PubMed ID: 4316894
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.